INSV now says it will be acquired by India’s Sun Pharma for $0.35/sh, jilting QLTI: http://finance.yahoo.com/news/insite-vision-sun-pharma-enter-202400378.html Sun Pharma was presumably the undisclosed company cited by INSV in prior press releases.